|
1. |
Expression of c-myc in Cutaneous Lymphomas and Pseudolymphomas |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 1-6
K. Peris,
L. Cerroni,
H. Kerl,
T. Radaszkiewicz,
S. Chimenti,
H. Höfler,
Preview
|
PDF (2412KB)
|
|
摘要:
The expression of the proto-oncogene c-myc was studied in tumorous skin lesions of (cutaneous) lymphoproliferative diseases (3 cases of pseudolymphoma, 8 cases of non-Hodgkin lymphoma and 1 case of lymph node involvement in mycosis fungoides) in a total of 12 patients, c-myc mRNA levels were quantified by Northern blot analysis followed by densitometric evaluation of the specific bands. Higher levels of c-myc mRNA expression were observed in lymphomas as compared with pseudolymphomas (p > 0.05). No significant differences in c-myc mRNA values were detected between B and T cell pseudolymphomas. Our results suggest that c-myc mRNA overexpression is associated with malignant lymphomas of the skin. We conclude that the measurement of c-myc mRNA levels may contribute to further characterize cutaneous lymphoproliferative diseases.
ISSN:1018-8665
DOI:10.1159/000247622
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
2. |
Immunohistochemical Expression of Epidermal Growth Factor Receptors in Nuclei of a Subpopulation of Keratinocytes and Sweat Gland Cells |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 7-9
C. Piérard-Franchimont,
A. Colige,
Arrese Estrada,
Ch.M. Lapière,
G.E. Piérard,
Preview
|
PDF (1145KB)
|
|
摘要:
We have raised a polyclonal antibody to the 170-kD epidermal growth factor receptor. We found an intercellular pattern of immunoreactivity in the epidermis as well as a positivity of the cytoplasm of keratinocytes and eccrine secretory cells. In some samples, a nuclear labelling was evidenced in these types of cells. There is a close resemblance in the topographical distribution of these cells with nuclear labelling and those synthesizing DNA under phytohaemagglutinin stimulation.
ISSN:1018-8665
DOI:10.1159/000247623
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
3. |
Lymphopenia and Decrease in the Total Number of Circulating CD3+ and CD4+ T Cells during ‘Long-Term’ PUVA Treatment for Psoriasis |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 10-14
G. Borroni,
C. Zaccone,
G. Vignati,
A. Fietta,
M. Gatti,
V. Brazzelli,
G. Rabbiosi,
Preview
|
PDF (2143KB)
|
|
摘要:
The relationship between high-dose PUVA treatment in psoriatic patients and peripheral T lymphocyte subsets (total number and percentage) has been studied. Of the two groups of patients considered, the first included 19 patients, all affected by chronic, progressively worsening psoriasis; they had never been previously treated by photochemotherapy. The second group included 13 psoriatic patients, who had received an average cumulative dose of 2,007.69 ± 1 191.05 J/cm2. The ‘long-term’ PUVA-treated group was assessed while undergoing maintenance therapy. No significant differences were found between untreated patients and healthy controls for any of the parameters considered. A significant reduction (p < 0.05) in the total number of lymphocytes in long-term PUVA-treated patients both versus untreated patients and controls was found. Furthermore, long-term PUVA-treated patients showed a significant reduction (p < 0.05) in the percentage of lymphocytes as compared with controls. The reduction in the total number of CD3+ and CD4+ T cells was, moreover, significant (p < 0.05) as compared with untreated patients. The impairment of circulating CD3+ and CD4+ T cells (total number) was only on the borderline of statistical significance vis-à-vis controls. These findings suggest the usefulness of a careful assessment of circulating T lymphocyte subsets in patients who undergo long-term PUVA th
ISSN:1018-8665
DOI:10.1159/000247624
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
4. |
Serological Profiles as Prognostic Clues for Progressive Systemic Scleroderma: The Italian Experience |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 15-20
A. Parodi,
P. Puiatti,
A. Rebora,
Preview
|
PDF (2231KB)
|
|
摘要:
Ninety-one patients with progressive systemic sclerosis have been examined both clinically and serologically in order to have a better prognostic insight. Three main serological profiles have been isolated. The patients with anticentromere antibodies (ACA) represented one third of the cases, developed skin sclerosis rather later and rarely exhibited ankyloses and ulcerations. The esophagus was commonly involved while the lung, heart and kidneys were not. ACA-positive patients were not identified with the CREST syndrome, as the latter disclosed other profiles with the same frequency. Patients with anti-Scl-70 antibody represented one fourth of the cases and had the fastest progression developing sclerosis in less than 5 years after the onset of Raynaud’s phenomenon. Ankyloses and lung fibrosis as well as joint, heart and kidney involvement, were found in most of them. Patients with anti-SSA/Ro antibodies were uncommon, but corresponded to a severe subset, having a fast progression and a constant involvement of the lung. Probably due to the rougher definition of their serology patients with antinucleolar, antispeckle-patterned and anti-Ku antibodies or without any detectable antibody could be defined less easily and corresponded to an intermediate position between ACA- and anti-Scl-70-positive patients. Though it is probably premature to trust it completely, a serological classification may provide the prognostic clues clinical classifications canno
ISSN:1018-8665
DOI:10.1159/000247625
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
5. |
Papaverine Hydrochloride in the Treatment of Atopic Dermatitis: A Double-Blind, Placebo-Controlled Crossover Clinical Trial to Reassess Safety and Efficacy |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 21-24
J. Shupack,
M. Stiller,
T. Meola, Jr.,
P. Orbuch,
Preview
|
PDF (1617KB)
|
|
摘要:
In a double-blind crossover study, oral papaverine hydrochloride in doses of 150–300 mg t.i.d. was compared to placebo as an adjunctive treatment of atopic dermatitis. Twenty patients completed both 2-week phases of the crossover during which time the physician’s weekly evaluation included an estimate of percentage skin involvement with disease, global evaluation and the grading of the erythema, scale and lichenification of a representative plaque. The patients’ evaluation included their assessment of the degree of pruritus, and an estimate of the percentage of the day pruritus was present as well as a global evaluation of disease. Papaverine demonstrated no statistically significant advantage over placebo for any of the parameters measured and was noted to cause transient asymptomatic liver function test abnormalities in 3 of the study pat
ISSN:1018-8665
DOI:10.1159/000247626
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
6. |
Adjuvant Treatment in Stage I and II Malignant Melanoma: A Randomized Trial between Chemoimmunotherapy and Immunotherapy |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 25-30
T. Castel,
J. Estapé,
N. Viñolas,
J.M. Mascaró,
J. Castro,
A. Vilalta,
R. Gratacós,
M. Daniels,
J. Palou,
J.J. Grau,
P. Iranzo,
Preview
|
PDF (2149KB)
|
|
摘要:
A randomized trial comparing chemoimmunotherapy (bacillus Calmette-Guérin + chemotherapy) and immunotherapy (bacillus Calmette-Guérin alone) was carried out in high-risk stage I and II malignant melanoma patients. Eighty-two evaluable patients were included. The follow-up median duration was 11 years. Recurrent melanoma developed in 28 patients (34%). The overall survival rate was 76% at 5 years and 65% at 10 years. There were no statistical differences in survival probability or disease-free survival (DFS) probability between the two treatment groups. Survival and DFS were also analyzed in relation to various prognostic factors. Statistically significant differences were only seen in a subset of 33 patients with lower limb malignant melanoma, the prognosis being better for the chemoimmunotherapy group in this location. Because of the small number of patients in each group, a week positive effect of either of these two treatments cannot be ruled out. Chemoimmunotherapy only seems to improve the prognosis of stage I or II malignant melanoma of the leg
ISSN:1018-8665
DOI:10.1159/000247627
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
7. |
Repeated Cultured Epidermal Allografts in the Treatment of Chronic Leg Ulcers of Various Origins |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 31-35
H. Beele,
J.M. Naeyaert,
M. Goeteyn,
M. De Mil,
A. Kint,
Preview
|
PDF (2221KB)
|
|
摘要:
Twelve patients with 16 leg ulcers, existing for at least 3 months and not responsive to conventional inpatient therapy of at least 3 weeks, were treated with repeated applications of cultured allogenic keratinocyte sheets. A marked decrease in size was seen in all ulcers but 2. Complete closure of the ulcer was seen in 62% of the ulcers within 8 weeks. Healing was due to enhanced granulation and increased epithelialization, starting from the periphery of the wound. This edge effect suggests that the epidermal allografts act by stimulation of migration and/or multiplication of the acceptor’s keratinocytes, rather than by take of the allograf
ISSN:1018-8665
DOI:10.1159/000247628
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
8. |
Clinical Comparison of Cefuroxime Axetil, Cephalexin and Cefadroxil in the Treatment of Patients with Primary Infections of the Skin or Skin Structures |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 36-43
W.M. Gooch III,
L. Kaminester,
G.W. Cole,
R. Binder,
M.R. Morman,
J.M. Swinehart,
M. Wisniewski,
H.M. Yilmaz,
J.J. Collins,
Preview
|
PDF (1628KB)
|
|
摘要:
This study was designed to compare the clinical and bacteriological efficacy of three oral cephalosporins, cefuroxime axetil, cephalexin and cefadroxil, in the treatment of patients with mild to moderate infections of the skin or skin structures. A total of 330 patients were enrolled at 10 centers and were randomly assigned to receive cefuroxime axetil 250 mg (n = 107), cephalexin 500 mg (n = 111) or cefadroxil 500 mg (n = 112), twice daily for 10 days. Patients were assessed for their clinical and bacteriological responses once during treatment (3–5 days) and twice after treatment (1–3 and 10–14 days). A total of 353 bacterial isolates were obtained: Staphylococcus aureus (41%) Staphylococcus epidermidis (33%) and Streptococcus pyogenes (5%). A satisfactory clinical outcome (cure or improvement) was achieved in 97% (89/92) 89% (80/90) and 94% (82/87) of the clinically evaluable patients treated with cefuroxime axetil, cephalexin or cefadroxil, respectively (p = 0.047, cefuroxime axetil vs. cephalexin). With respect to the eradication of the bacterial pathogens, a satisfactory outcome (cure or presumed cure) was obtained in 96% (69/72), 85% (60/71) and 93% (63/68) of bacteriologically evaluable patients treated with cefuroxime axetil, cephalexin and cefadroxil, respectively (p = 0.026, cefuroxime axetil vs. cephalexin). All three study drugs were well tolerated, with adverse events affecting the gastrointestinal system most commonly reported. There were no significant differences between treatment groups in the incidence of drug-related adverse e
ISSN:1018-8665
DOI:10.1159/000247629
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
9. |
Nail Changes as the First Sign of Systemic Amyloidosis |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 44-46
P.A. Fanti,
A. Tosti,
R. Morelli,
G. Galbiati,
Preview
|
PDF (1024KB)
|
|
摘要:
A 68-year-old man had had for 3 years a severe onychodystrophy involving all fingers and toes which clinically mimicked nail lichen planus. The nail biopsy showed amyloid deposits in the superficial dermis of the nail matrix. Physical, pathological and laboratory examinations confirmed the diagnosis of primary systemic amyloidosis. At the time of the diagnosis the patient did not present any other cutaneous sign of systemic amyloidosis.
ISSN:1018-8665
DOI:10.1159/000247630
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
10. |
Rapid Development of Multiple Squamous-Cell Carcinomas during Chronic Granulocytic Leukemia |
|
Dermatology,
Volume 183,
Issue 1,
1991,
Page 47-48
P. Disdier,
J.R. Harle,
J.J. Grob,
C. Weiller-Merli,
G. Magalon,
P.J. Weiller,
Preview
|
PDF (923KB)
|
|
摘要:
We report a 65-year-old patient who presented a rapid eruption of keratoses on sun-exposed areas and an explosive transformation into several squamous-cell carcinomas, occurring during the accelerated phase of a chronic granulocytic leukemia. Clinical findings resembled those usually descibed in xeroderma pigmentosum. The role of immunosuppression, chemotherapy and possible genetic predisposition is discussed.
ISSN:1018-8665
DOI:10.1159/000247631
出版商:S. Karger AG
年代:1991
数据来源: Karger
|
|